TETRALOGIC PHARMACEUTICALS CORP Share-based Payment Arrangement, Expense
TETRALOGIC PHARMACEUTICALS CORP reported Share-based Payment Arrangement, Expense of -$28.71 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for the quarter ending 2016-09-30 was -$28.71K, a 102.03% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for the quarter ending 2016-06-30 was $563.12K, a 56.45% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for the quarter ending 2016-03-31 was $929.25K, a 42.67% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for the quarter ending 2015-12-31 was $1.35M, a 50.81% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for fiscal 2015 was $5.68M, a 67.82% increase from fiscal 2014.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for fiscal 2014 was $3.38M, a 8.73% decline from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP share-based payment arrangement, expense for fiscal 2013 was $3.71M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 126 month |
|---|---|---|---|---|---|
| 2016-09-30 | -$28.71K 10-Q · filed 2016-11-03 | $534.40K derived: sum of 2 quarters · filed 2016-11-03 | $1.46M 10-Q · filed 2016-11-03 | $2.82M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | $563.12K 10-Q · filed 2016-08-11 | $1.49M 10-Q · filed 2016-08-11 | $2.85M derived: sum of 3 quarters · filed 2016-08-11 | $4.26M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-03-31 | $929.25K 10-Q · filed 2016-05-04 | $2.28M derived: sum of 2 quarters · filed 2016-05-04 | $3.70M derived: sum of 3 quarters · filed 2016-11-03 | $4.99M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $2.77M derived: sum of 2 quarters · filed 2016-11-03 | $4.06M derived: sum of 3 quarters · filed 2016-11-03 | $5.68M 10-K · filed 2016-03-16 | |
| 2015-09-30 | $1.41M 10-Q · filed 2016-11-03 | $2.70M derived: sum of 2 quarters · filed 2016-11-03 | $4.33M 10-Q · filed 2016-11-03 | $5.22M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | $1.29M 10-Q · filed 2016-08-11 | $2.91M 10-Q · filed 2016-08-11 | $3.81M derived: sum of 3 quarters · filed 2016-08-11 | $4.66M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $1.62M 10-Q · filed 2016-05-04 | $2.52M derived: sum of 2 quarters · filed 2016-05-04 | $3.36M derived: sum of 3 quarters · filed 2016-05-04 | $4.19M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | $898.32K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $1.74M derived: sum of 2 quarters · filed 2016-03-16 | $2.57M derived: sum of 3 quarters · filed 2016-03-16 | $3.38M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $844.35K 10-Q · filed 2015-11-04 | $1.67M derived: sum of 2 quarters · filed 2015-11-04 | $2.49M 10-Q · filed 2015-11-04 | $5.65M derived: sum of 4 quarters · filed 2015-11-04 | |
| 2014-06-30 | $828.45K 10-Q · filed 2015-08-05 | $1.64M 10-Q · filed 2015-08-05 | $4.80M derived: sum of 3 quarters · filed 2015-08-05 | $5.14M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $813.68K 10-Q · filed 2015-05-14 | $3.97M derived: sum of 2 quarters · filed 2015-05-14 | $4.32M derived: sum of 3 quarters · filed 2015-05-14 | $4.40M derived: sum of 4 quarters · filed 2015-05-14 | $5.92M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $3.50M derived: sum of 2 quarters · filed 2015-02-26 | $3.58M derived: sum of 3 quarters · filed 2015-02-26 | $3.71M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $341.17K 10-Q · filed 2014-11-05 | $423.65K derived: sum of 2 quarters · filed 2014-11-05 | $547.07K 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $82.48K 10-Q · filed 2014-08-05 | $205.90K 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | $123.42K 10-Q · filed 2014-05-08 |